Sean Smith - Interim CFO, Prin Acct Off at Neurogene Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim CFO, Prin Acct Off
Issuer Symbol
NGNE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Sean Smith since 14 Feb 2025

Holdings reported by Sean Smith for Neurogene Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 21,637 $14,990 $0.6928 11 Aug 2023 Direct
Restricted Stock Units 0 10 Aug 2023 Direct Common Stock

Transactions reported by Sean Smith for Neurogene Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.